The clinical relevance of heme-induced TLR4 activation has been demonstrated in murine SCD, where genetic deletion or pharmacological inhibition of TLR4 prevented heme-induced vaso-occlusion, mainly through activation of endothelial cells (35). Here, TLR4 is linked to Schnyder corneal dystrophy.